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Purpose: To evaluate the safety and efficacy of higher fluence cornea collagen cross 
linking (CXL).
Methods: Twenty-one patients with bilateral keratoconus had randomized CXL in one eye 
(group A) with 7 mw/cm2 for 15 minutes; the other eye (group B) had the standard 3 mw/cm2 
for 30 minutes; 50 um PTK with the Eye-Q 400 Hz Excimer laser (Wavelight, Erlagen, G  ermany) 
was used for epithelial removal. The patients were evaluated postoperatively at the following 
intervals: day 1, day 4, month 1, month 3, and then every 6 months.
Results: For groups A and B respectively, in mean values: uncorrected distance visual acuity 
(UDVA) improved from 20/60 to 20/38, and 20/62 to 20/40; best corrected visual acuity (BCVA) 
from 20/30 to 20/25 in both groups; mean sphere was reduced by 2.5 and 2.1 diopters; mean 
cylinder was reduced by 2.9 and 2.5 diopters on average; Steepest K was reduced from 49.5 to 
46.1, and from 48.7 to 45.8 diopters. There was no ectasia progression in any of the cases during 
the follow-up time studied. There was no change in the endothelial cell count. All patients 
returned to full activities postoperatively within a month. Four cases from group A and five 
cases from group B had delayed epithelial healing (completed by postoperative day 9). No other 
adverse effects were noted in any of the cases studied. Mean follow-up was 46 months (18–56). 
Corneal optical coherence tomography (OCT) revealed diffused light scattered in anterior two-
thirds of the cornea stroma, which was more intense and much broader in diameter in group A 
than in group B.
Conclusion: This novel technique offers similar clinical results in ectasia stabilization without 
any adverse effects noted.
Keywords: cornea collagen cross linking (CXL), ectasia management, keratoconus manage-
ment, higher fluence ultraviolet light
Introduction
The management of keratoconus (KCN) with collagen cross linking (CXL), utilizing 
UV irradiation and simultaneous topical riboflavin administration, has been studied 
at length. This has taken place both in laboratory work as well as clinical work,1–14 
and received the CE mark of approval, in December 2006, for clinical use in countries 
in the European Union. The standard technique described by Wollensak et al involves 
partial or complete central epithelial removal, followed by topical administration of 
riboflavin 0.1% solution in order to achieve intra-stromal penetration.1
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We theorized that by increasing the UV light fluence we 
targeted the following: (1) a faster procedure, as the fluence 
time is shortened, and (2) shorter keratocyte exposure time 
and potentially less fibrocyte cornea damage caused.
Methods
Twenty-one patients with bilateral progressive keratoconus were 
studied. The study is a prospective randomized comparative case 
series. These patients were selected with the following criteria:
1.  Topographic and tomographic evidence of keratoconus 
(K . 45 and/or inferior steepening greater than 1 diopter 
to the superior half of the cornea, and 1 diopter of tomo-
graphic cylinder progression over 1 year.)
2.  Minimum cornea thickness at or over 450 microns.
3.  Age at or over 18 years.
4.  Refer to Table 1 for pre-op and post-op: refraction, 
corrected distance visual acuity (CDVA), UDVA, IOP, 
corneal endothelial cell count, and the figures for ultra-
sound cornea pachymetry (UCP), cornea tomography 
(Oculyzer; Wavelight, Erlangen, Germany), and OCT 
cornea imaging (Optovue Inc, Fremont, CA), with a 
minimum of 28 months follow-up.
Surgical technique
Phototherapeutic keratectomy (PTK) epithelial removal: 
under topical 1% proparacaine anesthesia (Alcaine, Alcon, 
Fort Worth, Texas), the Wavelight 400 Hz Excimer laser was 
used for PTK with the parameters of 6.5 mm optical zone, 
50 um depth of tissue removal. This mode was used instead 
of manual epithelial removal for several reasons: (1) to avoid 
ethanol-related cornea toxicity, and (2) to use the epithelium 
as a masking agent in epithelial removal, anticipating that 
this mode would perhaps remove Bowman’s membrane and 
possibly some stroma over the area of the cone, as the epi-
thelium there is usually significantly thinner.
Collagen cross-linking: 0.1 ml of 0.1% of riboflavin solu-
tion was administered every 30 seconds for 5 minutes 
(10 drops) until the de-epithelialized cornea was a bright yellow 
color, due to the presence and stromal infiltration of the ribo-
flavin solution. The preceding removal of Bowman’s membrane 
at the cone area facilitated rapid riboflavin solution diffusion 
within the stroma within 5 minutes. The cornea was then 
exposed to UV light: group A with 7 mW/cm2 for 15   minutes 
and group B for the standard 3 mW/cm2 for 30 minutes.
A UV irradiation source of an average 370 nm wavelength 
(365–375 nm) was used to irradiate the corneal surface. The 
effective fluence at the corneal surface was calibrated at 
7 mW/cm2 and lasted 15 minutes. The total amount of UV 
irradiation d  elivered at an 8 mm-diameter corneal plane was 
calculated to be 6.3 joules (in comparison to 5.4 joules for 
group B).
Post-op medicines included topical ofloxacin four times 
daily for 1 week, and a combination of chlorampenicol and 
1% prednisolone acetate (Dispersadron C, Alcon) four times 
daily for a month and twice daily for another month. Vitamin 
C – 1000 mg per day – was administered orally for 2 months, 
and patients were encouraged to avoid direct sunlight. The 
patients were evaluated at postoperative day 1, day 4, month 
1, month 3, and then every 6 months.
results
Table 1 documents the pre- and post-UDVA, CDVA, 
  Steepest K, Min K, endothelial cell count (ECC), Pentacam 
thickness, OCT thickness and hyper-reflectivity. The results 
for groups A and B in mean values respectively are: UDVA 
improved from 20/60 to 20/40, BSCVA from 20/30 to 20/25, 
mean sphere was reduced by 2.4 diopters, mean cylinder was 
reduced by 2.9 diopters on average, Steepest K was reduced 
from 49.5 to 46.1 diopters. There was no ectasia progression 
in any of the cases during the follow-up time studied and 
there was no change in the endothelial cell count.
There was an initial reduction of cornea pachymetry at 
1 month, at about 20% of the preoperative pachymetry 
m  easurement. The mean thinnest cornea pachymetry 
appeared to increase at 18 months follow-up by 25%, on 
average, when compared to postoperatives in the first month, 
and by 5% when compared to the preoperative pachymetry 
measurement. All patients returned to full activities postop-
eratively within a month. Four cases from group A and five 
cases from group B had delayed epithelial healing (completed 
in day nine). No other adverse effects were noted in any of 
the cases studied. Mean follow-up was 46 months (18–56).
Representative pre- and postoperative tomographies for 
two eyes from group A, along with their topographic 
Table 1 Summary of perioperative data
Variable 7 mW/cm2 –  
group A
3 mW/cm2 – 
group B
UDVA pre-op 20/60 20/62
UDVA post-op 20/38 20/40
CDVA pre-op 20/30 20/30
CDVA post-op 20/25 20/25
Spherical equivalent change -2.5D (1.4–3.1) -2.3D (1.3–2.9)
refractive cylinder change -2.9D (1.5–3.4) -2.8D (1.6–3.3)
Topometric cylinder change 
(steepest K)
-3.4D (1.6–4.1) -2.9D (1.7–3.8)
Endothelial cell change -100 -250
Delayed epithelial healing 4 5
Complications 0 0
Abbreviations:  UDVA,  uncorrected  distance  visual  acuity;  CDVA,  corrected 
distance visual acuity; D, diopter.





Figure 1 Pre (left), post (center), and difference (right) topography maps from an indicative case of Group A.
Figure 2 Pre (left), post (center), and difference (right) topography maps and keratometric data of an additional indicative case of Group A.
d  ifference, are displayed in Figures 1 and 2. Slit lamp 
  biomicroscopy revealed no long term epithelial defects, and 
diffuse light scattering in anterior 2/3 of the cornea stroma, 
consistent with our clinical findings from the standard CXL 
technique, was more intense and much broader in diameter 
in group A (Figures 3 and 4).
Discussion
We have clinically applied CXL, utilizing ultraviolet 
A irradiation and riboflavin solution in cornea ectasia, 
keratoconus and bullous keratopathy over the last 6 
years.12–16,18–24 We have previously presented and reported 
the employment of higher fluence CXL with riboflavin 
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solution administration via a femtosecond created   intracorneal 
pocket.22
CXL was shown to have a documented benefit to corneal 
ectatic disorders. One of the shortcomings with the standard 
Dresden protocol are lengthy exposure duration (30 minutes). 
Post-operative pain, delayed epithelial healing, and delayed 
visual rehabilitation for 1 to 2 weeks postoperatively are 
some of the other shortcomings.
The contributing elements in the CXL photo-oxidative 
and biochemical reactions are riboflavin, UVA light, oxygen, 
and stromal collagen. There is a potential limit of oxygen 
availability and absorption by riboflavin within the stroma 
during the length of standard cross-linking procedure. If the 
riboflavin was already present in the cornea stroma, a larger 
portion of UVA light may pass through the cornea epithelium 
and produce the photochemical reaction in the cornea stroma 
instead of the eye’s surface, therefore facilitating more effi-
cient intra-stromal cross-linking and potentially less collateral 
toxicity to the cornea surface.
In the standard technique, the riboflavin-soaked cornea 
stroma absorbs the UVA light and, with oxygen, produces 
a photo-oxidative reaction (type 2). The product is a free 
radical oxygen molecule, which facilitates a biochemi-
cal reaction within stromal collagen. We speculate that 
it generates fiber to fiber bonds, or bonds between proteo-
glycans and collagen fibrils,25 leading to higher stromal 
rigidity.
The novel method described herein, where higher fluence 
UV light is used with shorter exposure, appears to be safe 
and effective in stabilizing keratoconus.
OD CL-line SSI = 35.4 6.00 mm scan length
250 µm
Figure 3 A 1 year postoperative cornea OCT from a case from Group A (also studied in Figure 1). There is very wide and deep stromal hyper-reflectivity representing 
effective large stromal volume cross-linking.
250 µm
OS CL-line SSI = 34.5 6.00 mm scan length
Figure 4 This is an 18 month postoperative cornea OCT of a case from Group A (same case shown in Figure 2). The extreme cornea thinning is evident, along with deep 
stroma hyper-reflectivity representing effective large stromal volume cross-linking.
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This technique appears to be similar but more   comfortable 
for the patients. It requires half UV exposure time, has similar 
first night discomfort, and all patients returned to pre-op visual 
function with no epithelial defect by week one (on average).
Would there be a reduced stromal keratocyte loss, com-
pared to that reported with the standard technique,17 because 
there is a shorter duration of UV exposure with higher fl  uence? 
Most human cells are believed to be more resistant to short or 
pulsed exposure to UV light, rather than longer and continuous 
exposure. Does this procedure pose less risk for postoperative 
infectious keratitis, again due to the shorter duration and the 
higher fluence providing a “  dis-infective effect”?
In our early clinical experience, this new technique has 
been very rewarding in regard to the cross-linking effect.
This technique may become an alternative CXL technique 
for the prevention and stabilization of cornea ectasia. In our 
opinion, it may become an effective application as an adjunct 
prophylactic treatment in routine ‘Laser Assisted In-Situ 
Keratomileusis’ (LASIK) cases, when cornea ectasia may 
be a possible concern. Further studies and longer follow-up 
are needed to validate these data.
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